Breakthrough Properties is a life sciences real estate company that develops, acquires, and operates laboratory and office facilities for biotechnology and pharmaceutical research. Formed as a joint venture between Tishman Speyer and Bellco Capital, the firm focuses on providing modern wet-lab and related R&D environments suited to companies across the drug discovery and development spectrum.
The company concentrates its portfolio in leading innovation hubs in the United States and Europe, delivering multi-tenant labs, incubator-ready space, and build-to-suit campuses. Its properties serve tenants ranging from early-stage ventures to established biopharma organizations, supporting activities in chemistry, biology, and translational research.